Previous 10 | Next 10 |
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which allowed financial results for the year 2022 exceeding management’s beginning of year...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list is a m...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend C...
Summary All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 6% and a median increase of 5.8%. There are twenty-one increases for next week, up from eight last week. Companies...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list ...
Utah Medical Products ( NASDAQ: UTMD ) declares $0.295/share quarterly dividend , 1.7% increase from prior dividend of $0.290. Payable Jan. 4; for shareholders of record Dec. 16; ex-div Dec. 15. See UTMD Dividend Scorecard, Yield Chart, & Dividend Growth. ...
SALT LAKE CITY, UT / ACCESSWIRE / November 1, 2022 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine and one-half cents ($.295) per share of common stock payable on January 4, 2023 to shareholders of record at ...
Utah Medical Products press release ( NASDAQ: UTMD ): Q3 GAAP EPS of $1.178. Revenue of $12.95M (+3.0% Y/Y). For further details see: Utah Medical Products GAAP EPS of $1.178, revenue of $12.95M
SALT LAKE CITY, UT, Oct. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - In the third calendar quarter (3Q) of 2022, despite significant cost inflation, supply chain disruption, litigation expenses and negative impact of a stronger U.S. Dollar on foreign currency sales, Utah Medical Pro...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...
News, Short Squeeze, Breakout and More Instantly...
Utah Medical Products Inc. Company Name:
UTMD Stock Symbol:
NASDAQ Market:
Utah Medical Products Inc. Website:
2024-06-25 08:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously announced projections for calendar year 2024. Summary of results . The following is a summary com...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...